The azlB locus of Bacillus subtilis was defined previously by a mutation conferring resistance to a leucine analog, 4-azaleucine (J. B. Ward, Jr., and S. A. Zahler, J. Bacteriol. 116:727-735, 1973). In this report, azlB is shown to be the first gene of an operon apparently involved in branched-chain amino acid transport. The product of the azlB gene is an Lrp-like protein that negatively regulates expression of the azlBCDEF operon. Resistance to 4-azaleucine in azlB mutants is due to overproduction of AzlC and AzlD, two novel hydrophobic proteins.
MATERIALS AND METHODS
Bacterial strains and culture media. Bacterial strains used in this study are listed in Table 1 . B. subtilis strains were grown at 37°C in TSS minimal medium (20) with 0.5% glucose and a 0.2% nitrogen source, in Spizizen minimal medium with 0.5% glucose (42) , or in DS nutrient broth medium (20) . The same media with addition of agar or tryptose blood agar base medium (Difco) was used for growth of bacteria on plates. Strains carrying azl-lacZ transcriptional fusions integrated at the amyE locus were isolated after transformation of strain SMY with derivatives of pJPM82 (Table 1 ; also, see below), with selection for resistance to erythromycin and screening for loss of ␣-amylase production, which indicated a double-crossover, homologous recombination event. The Amy phenotype was assayed with colonies grown overnight on tryptose blood agar base-0.2% starch plates (20) . The azaleucine resistance (Azl r ) phenotype was determined on TSS-agar plates containing 100 to 200 g of 4-D,L-azaleucine (Sigma Chemical Co.) per ml. L broth or L agar (32) was used for growth of E. coli strains. The following antibiotics were used when appropriate: chloramphenicol (2.5 to 5 g/ml), neomycin (5 g/ml), tetracycline (15 g/ml), phleomycin (1.0 g/ml), and a combination of erythromycin (0.5 g/ml) and lincomycin (12.5 g/ml) for B. subtilis strains and ampicillin (50 to 100 g/ml), kanamycin (25 g/ml), chloramphenicol (10 g/ml), and tetracycline (10 g/ml) for E. coli strains.
DNA manipulations and transformation. Methods for plasmid isolation, agarose gel electrophoresis, use of restriction and DNA modification enzymes, DNA ligation, Southern blot analysis, and PCR were as described by Sambrook et al. (39) . B. subtilis chromosomal DNA was isolated by a previously published procedure (20) . Preparation of electroporation-competent cells and plasmid transformation of E. coli strains with a GenePulser apparatus (Bio-Rad Laboratories) were done as described elsewhere (14) . Transformation of B. subtilis by chromosomal or plasmid DNA was performed by the method of Dubnau and Davidoff-Abelson (15) . DNA probes were radiolabeled with [␣- 32 P]dCTP by using the Rediprime DNA labeling system (Amersham Life Science) according to the manufacturer's instructions.
Plasmid constructions. Plasmids used in this work are shown in Fig. 1 and 2A or are described in the text.
To clone the azlB region from a B. subtilis strain of the 168 lineage, the chromosomal DNA of strain 1A1 was completely digested with HindIII and size-fractionated by centrifugation in a 10 to 40% sucrose gradient. Two-to 6-kb fragments were ligated to HindIII-digested pBluescript II KS(Ϫ) (Stratagene, Inc.) and introduced into E. coli SURE by transformation. The resulting library, plated onto Hybond N membranes (Amersham Life Science), was screened with the radiolabeled 1.25-kb NsiI 1 -EcoRI 2 fragment of plasmid pBB408 (5), essentially as described by Sambrook et al. (39) . The clone containing plasmid pMG001, harboring the 4.2-kb HindIII 2 -HindIII 3 fragment (Fig. 1) , was kept. By a similar procedure, the 4.6-kb PstI 1 -PstI 2 fragment (pMG042; Fig. 1 ) was isolated by screening a library of 4-to 9-kb PstI fragments.
To clone the chromosomal region containing the azlB101 mutation, plasmid pBB589 ( Fig. 2A) , a derivative of pBB544 (described below), was introduced into the chromosome of strain BB34 (azlB101) by transformation via single-crossover, homologous recombination. The chromosomal DNA of the resulting strain was digested with HindIII, self-ligated, and introduced into E. coli JM107 by transformation. The isolated plasmid, pBB600, contained the 1.2-kb AccI 1 -HindIII 3 fragment of B. subtilis DNA (Fig. 1) .
To construct plasmid pBB544, the neo gene from pBEST501 (27) was excised as a 1.3-kb PstI-NotI fragment, treated with the large (Klenow) fragment of E. coli DNA polymerase I, and inserted at the filled-in AflIII site of pBluescript SK(Ϫ) (Stratagene, Inc.). The direction of neo transcription in pBB544 is away from the polylinker region; a plasmid with the opposite orientation of neo was called pBB543.
To construct most plasmids containing azl-lacZ transcriptional fusions ( Fig. 2A ), appropriate DNA fragments from different derivatives of pBB544 ( Fig. 2A) were subcloned between the BamHI and EcoRI sites of pJPM82. The latter plasmid was made by J. Mueller (33) by first blunt-ending the EcoRI site of pJPM15 (34) to create pJPM80 and then replacing the 2.2-kb HindIII-SacI fragment with the 2.1-kb HindIII-SacI fragment of pJPM3 (34) . This placed the lacZ reporter gene in pJPM82 under the control of the spoIIAA ribosomal binding site (17) with unique HindIII, BamHI, and EcoRI sites upstream. Plasmid pBB528 ( Fig. 2A) was made by deleting the 1.2-kb HindIII fragment of pBB527 ( Fig. 2A ). An orf105-lacZ translational fusion (pBB535; Fig. 2A ) was constructed by cloning the 1.4-kb HindIII 4 -BglII fragment, cleaved from pBB426 (5) with EcoRI (a vector site) and BglII, between the EcoRI and BamHI sites of pJPM96. The latter plasmid was made by J. Mueller (33) by replacing the EcoRI-ClaI fragment of pJF751 (18) with the 0.8-kb EcoRI-ClaI fragment of pSGMU31 (17) . The structure of the fusion junction in pBB535 was confirmed by sequencing. Construction of azlB null mutants. To make an azlB deletion-insertion mutant, the 1.0-kb EcoRI (filled in)-HincII fragment of pBLE1 (21) , containing the ble gene, was ligated to pMG001 ( Fig. 1) cleaved with AflII (filled in). The resulting plasmid, p⌬lrp1 (Fig. 1) , which has the ble gene reading in the direction opposite to that of azlB, was used to transform strain 1A1 to phleomycin resistance, determined by the ble gene. The substitution of the ⌬azlB::ble allele for the wild-type azlB gene due to a double-crossover, homologous recombination event in one of the transformants, LUW5, was confirmed by Southern blot analysis (data not shown).
Two more deletions within the azlB gene were created by cutting out the 0.29-kb AflII fragment of pBB577 ( Fig. 1 ) and religating the remaining fragment after filling in its ends. Plasmid pBB578 (⌬azlB1), in which one A nucleotide was missing at the AflII-AflII junction, was first isolated (Fig. 1) . The tet gene excised from pBEST307 (26) as a 1.9-kb HindIII-EcoRI fragment and blunt-ended by treatment with the Klenow fragment of E. coli DNA polymerase I was inserted at the NruI site of pBB578 (0.4 kb upstream of the azlB coding region), creating pBB581 and pBB582 (in which tet is transcribed in the same direction as azlB and in the opposite direction, respectively) ( Fig. 1) . pBB581 was introduced into strain SMY by transformation, with selection for tetracycline resistance and screening for neomycin sensitivity (a vector marker), indicating a double-crossover, homologous recombination event. The replacement of the wild-type chromosomal azlB gene by the ⌬azlB1 allele in strain BB272 was confirmed by sizing the PCR fragments generated from the azlB locus (data not shown).
The ⌬azlB1 deletion shifts the reading frame of the distal part of azlB and causes premature termination of translation. In pBB587, similar to pBB578 but with a correct AflII junction (Fig. 1) , the deletion does not alter the reading frame of azlB (and creates the PacI site at its junction). pBB587 was introduced by a single-crossover, homologous recombination event into the chromosome of strain SMY, with selection for neomycin resistance (a vector marker). About derivative in which the integrated pBB587 was apparently excised from the chromosome and lost was isolated. Replacement of the wildtype azlB gene by the ⌬azlB2 allele in strain BB274 and excision of pBB587 were confirmed by sizing the PCR fragments generated from the azlB locus (data not shown).
Inactivation of the azlCD and brnQ genes. Plasmids pBB586 and pBB493 ( Fig.  1 ), carrying internal fragments of the azlC and brnQ genes, respectively, were integrated into the chromosome of strain SMY or BB274 (⌬azlB2) via a singlecrossover recombination event. These integration events disrupted the open reading frames of azlC or brnQ.
FIG. 1.
Restriction map of the azlB region and plasmids carrying different parts of this region. At the top, the restriction map of part of the 12.7-kb chromosomal segment cloned in previous work (5) is shown. The restriction sites are abbreviated as follows: A, AflII; Ac, AccI; B, BglII; Bc, BclI; E, EcoRI; En, EcoNI; H, HindIII; N, NsiI; Nd, NdeI; Nr, NruI; Pv, PvuII; P, PstI; and S, SacI. Only relevant AccI, BclI, PvuII, NdeI, and NruI sites are shown. Plasmids pMG001, p⌬lrp1, and pMG042 are derivatives of pBluescript II KS(Ϫ) (Stratagene, Inc.); plasmids pMG033 and pMG035 are derivatives of pBLE1 (21); plasmid pMG041 is a derivative of pHV32 (36) ; plasmids pBB404, pBB493, pBB598, pBB599, and pBB706 are derivatives of pJPM1 (34) ; and other plasmids are derivatives of pBB544 (this work). Construction of most plasmids is described in Materials and Methods; other plasmids were constructed by deleting or subcloning fragments of the azlB region. E. coli BU1255 was used to isolate plasmid DNA sensitive to BclI. x, location of the azlB101 mutation within pBB600.
Plasmids pBB579, pBB597, and pBB706 ( Fig. 1) were integrated into the chromosome of strain SMY or BB274 (⌬azlB2) via a single-crossover recombination event. These integration events separated azlC, azlD, brnQ, and orf105 (for pBB579), azlD, brnQ, and orf105 (for pBB597), or only brnQ and orf105 (for pBB706) from the azlB promoter.
Construction of an azlCDE null mutant. Plasmid pBB419 (5) was cut with NsiI to delete the 1.7-kb NsiI 2 -NsiI 3 fragment containing the azlD gene and parts of azlC and brnQ and ligated with the 1.3-kb neo gene excised from pBEST501 (27) with PstI. Plasmid pBB598 has the neo gene transcribed in the direction opposite to that of azlB (Fig. 1 ). pBB599 is a version of pBB598 in which the 1.7-kb PstI-EcoNI fragment was deleted (Fig. 1 ). These two plasmids were introduced into strain SMY or BB274 (⌬azlB2) by transformation, with selection for neomycin resistance and screening for chloramphenicol sensitivity, an indication of a double-crossover recombination event. Replacement of the wild-type chromosomal azlCDE genes by the ⌬azlCDE::neo allele in strains BB284 and BB285 was confirmed by sizing the PCR fragments generated from this chromosomal region (data not shown).
Construction of a cypA null mutant. The 1.0-kb EcoRI 1 -SacI 1 fragment ( Fig.  1 ) was ligated to pBLE1 (21) that had been cut with the same enzymes to create pMG030, and then the 1.5-kb PvuII-HindIII 3 fragment ( Fig. 1 ) was ligated to pMG030 cleaved with HincII and HindIII. The resulting plasmid, pMG033 ( Fig.  1) , was used to transform strain 1A1 to phleomycin resistance. The deletioninsertion within the chromosomal cypA gene arising from a double-crossover recombination event was confirmed by Southern blot analysis (data not shown).
FIG. 2. (A)
Construction and activities of various azl-lacZ fusions. Plasmid pJPM82 (see Materials and Methods) was used for construction of most fusions (pBB525 to pBB533 and pBB536), which were subsequently integrated by double-crossover recombination at the amyE locus of the B. subtilis chromosome. Plasmid pJPM96 (see Materials and Methods) was used for construction of an orf105-lacZ (pBB535) translational fusion; this fusion was integrated at the azl-brnQ region of the chromosome by single-crossover recombination. Plasmids pBB588 to pBB590, pBB592, pBB593, pBB596, pBB723, pBB725, and pBB727 are derivatives of pBB544 (this work) and were used as intermediates in construction of lacZ fusions. The restriction sites are abbreviated as for Fig. 1 ; additional relevant sites are SphI (Sh) and SspI (Ss). Strains carrying the respective fusions (Table 1) were grown in TSS glucose-ammonia medium or DS nutrient broth medium (DSM). The presented activities of lacZ fusions were determined at the middle of exponential phase (optical density of ϳ0.5 at 600 nm), when those activities were close to maximal. ␤-Galactosidase activity is expressed in Miller units as described in Materials and Methods. All the numbers are averages of at least two experiments, and the mean errors did not exceed 20%. NA, not applicable (a full-length allele of azlB is present within a fusion); ND, not determined. (B) Sequence of the azlB regulatory region. A likely initiation codon, a possible ribosomal binding site, and the putative Ϫ10 and Ϫ35 promoter regions of the azlB gene (underlined) and the direction of translation (horizontal arrow) are indicated. The coordinates are given with respect to the azlB translation start point. The NruI and SspI sites used to construct truncated azlB-lacZ fusions are shown, with the beginning of the azlB sequence within these fusions indicated (vertical arrows). The AccI site used to construct a full-length azlB-lacZ fusion lies at positions Ϫ337 to Ϫ332.
Construction of an orf91 null mutant. The 0.6-kb EcoRI 2 -PvuII fragment ( Fig.  1 ) was ligated to pBLE1 (21) that had been cleaved with EcoRI and SacI (filled in) to create pMG031, and then the 1.2-kb AccI 1 (filled in)-HindIII 3 fragment (Fig. 1 ) was ligated to pMG031 cleaved with HincII and HindIII. The 2.9-kb EcoRI-HindIII fragment of the resulting plasmid, pMG035, was subcloned in pHV32 (36) to yield pMG041 (Fig. 1) . The latter plasmid was used for transformation of strain 1A1, with selection for phleomycin resistance and screening for chloramphenicol sensitivity. The double-crossover recombination event replacing the chromosomal orf91 gene with the ble gene in one of the transformants, LUW7, was confirmed by Southern blot analysis (data not shown).
Disruption of orf182. Plasmid pBB404 (Fig. 1) , containing an internal 0.28-kb HindIII 2 -EcoRI 1 fragment of an open reading frame corresponding to Јorf182, was integrated into the chromosome of strain SMY by transformation via a single-crossover, homologous recombination event.
DNA sequencing. DNA fragments containing the azlB region were sequenced on both strands by the dideoxy chain termination method of Sanger et al. (40) , using vector-or azlB region-specific oligonucleotides as primers. Nested deletions in pMG001 (Fig. 1) were obtained by using exonuclease III and mung bean nuclease as described elsewhere (1) . Plasmid double-stranded DNA to be sequenced was purified by a modification of the boiling lysis protocol (24) . A Sequenase reagent kit (Amersham Life Science) was used according to the protocol of the manufacturer.
DNA and protein sequences were analyzed by using DNA Strider, the package of programs provided by the University of Wisconsin Genetics Computer Group (12) , and the BLAST program (2) .
Enzyme assays. ␤-Galactosidase activity was determined as described previously (5). The specific activity was expressed in Miller units (32) .
Nucleotide sequence accession number. The nucleotide sequence of the azlB region reported here has been assigned GenBank accession no. Y11043.
RESULTS
DNA sequence of the azlB region. The cloning of a 12.7-kb DNA segment from the 233°region of the B. subtilis chromosome and the sequence of a 3.7-kb part of this segment, containing the brnQ and gltR genes, were recently reported (5). The previously identified azlB locus (46) was shown to reside within this region of DNA, to the left of the brnQ gene ( Fig. 1) (5). The sequence of the 4,958-bp HindIII 2 -HindIII 4 chromosomal fragment (Fig. 1 ) from strain 168, immediately adjacent to the previously sequenced segment and overlapping the site of the azlB101 mutation, was determined in the present work. Partial sequences of this region from strain SMY were identical to corresponding sequences from strain 168 (4).
The five complete open reading frames and one partial open reading frame found in this region are described in Table 2 . All open reading frames in this region are transcribed in the same direction, counterclockwise with respect to the standard B. subtilis chromosomal map (3). The 1.9-kb PstI 1 -NsiI 2 fragment that was able to rescue the azlB101 mutation (5) contained all or parts of four of these open reading frames. To localize more precisely the position of the mutation, we showed that it could not be rescued by the 1.5-kb EcoRI 2 -EcoNI fragment of pBB580 (Fig. 1) , placing the azlB101 mutation within the 0.4-kb interval between the EcoNI and NsiI 2 sites or upstream of and very close to the EcoNI site (Fig. 1) . The appropriate region of the chromosomal DNA from the azlB101 mutant was cloned and sequenced to show that the mutation represented a deletion of one C nucleotide between positions 3583 and 3585, ϳ50 bp downstream of the EcoNI site. An open reading frame encoding 157 amino acids preceded by a putative ribosome binding site overlapped the site of the azlB101 mutation. Computer analysis of the deduced AzlB sequence showed that it belongs to a family of proteins that includes E. coli transcription regulators AsnC (29) and Lrp (9, 35) and their homologs. Phylogenetic analysis of this family separates it into several distinct groups and shows that AzlB is not particularly close to either the Lrp or AsnC subfamily (Fig. 3) . Several archaeal members of the family are close to the AsnC subfamily or belong to the AsnC subfamily (Fig. 3) .
Phenotype of an azlB null mutant. A large DNA segment internal to the azlB gene was deleted without altering the reading frame of the distal part of the gene (see Materials and Methods and Fig. 1 ). This deletion removed 61% of the azlB coding region, including codons 22 to 43, encoding the putative helix-turn-helix DNA binding motif (13) of AzlB. When introduced into the B. subtilis chromosome, the ⌬azlB2 mutation had no apparent effect on growth of cells in broth or in defined media. The deletion conferred resistance to 4-azaleucine, the level of which was indistinguishable from that of the azlB101 mutant (46) . A similar but out-of-frame deletion mutation, ⌬azlB1, conferred an identical phenotype. We conclude that azlB101 is also a loss-of-function mutation, reflecting a frameshift starting from codon 94 and premature translation termination of the mutant AzlB protein. A ⌬azlB::ble mutation (see Materials and Methods and Fig. 1 plates (MIC, 25 to 50 g/ml compared with 5 to 10 g/ml for a wild-type strain and Ͼ200 g/ml for the ⌬azlB2 and azlB101 mutants [data not shown]). Role of AzlB in expression of the azlB gene. Transcriptional fusions of the azlB gene to the lacZ reporter gene were constructed as described in Materials and Methods and inserted by double-crossover recombination at the amyE locus. The azlBlacZ fusion, containing the entire intergenic region between the orf91 and azlB genes (as in pBB525 [ Fig. 2A]) , was not significantly expressed in a wild-type background of strain BB831 in glucose-ammonia minimal medium (Fig. 4A) and was moderately induced during the exponential growth phase in nutrient broth medium (Fig. 4B) . Addition of leucine or a mixture of leucine, isoleucine, and valine to minimal medium did not affect azlB-lacZ expression (data not shown). Replacement of ammonia by 0.2% proline in minimal glucose medium enhanced azlB-lacZ expression three-to fourfold; addition of 0.2% Casamino Acids (Difco) to glucose-ammonia medium activated expression of this fusion sixfold (data not shown).
In a strain carrying the in-frame ⌬azlB2 mutation, the same fusion turned out to be highly active in minimal glucose-ammonia medium (Fig. 4A ) or in nutrient broth medium (Fig.  4B) 4 . Expression of an azlB-lacZ fusion. Strains BB831 (azlB ϩ ) and BB834 (⌬azlB2) were grown in TSS glucose-ammonia medium (A) or in DS nutrient broth medium (B). ␤-Galactosidase activity in azlB ϩ cells (circles) and ⌬azlB2 (squares) is expressed in Miller units as described in Materials and Methods. Growth curves of BB831 (triangles) and BB834 (diamonds) reflect the optical density at 600 nm (OD 600 ). ␤-Galactosidase activity in azlB ϩ cells is also shown on a different scale (inset). Each experiment was repeated at least twice, with very similar results (in each case, data from a single experiment are presented).
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on October 14, 2017 by guest http://jb.asm.org/ pression of the azlB-lacZ fusion was observed in the azlB101 mutant (data not shown). Other members of the AsnC-Lrp family (10, 28, 29, 31, 38, 45) are also negative autoregulators. In the absence of AzlB, expression of azlB-lacZ in nutrient broth medium was still induced during the exponential growth phase (Fig. 4B) ; this effect was much less apparent, if present at all, in minimal medium (Fig. 4A) . Expression of the azlBlacZ fusion was shut off at the beginning of stationary phase (Fig. 4) . This decline of ␤-galactosidase activity was not dependent on the presence of AzlB (Fig. 4B ) and was not prevented by introduction of a spo0A mutation abolishing sporulation (data not shown). Deletion analysis of the azlB promoter region showed that only 135 bp upstream of the azlB coding region (as in pBB529 [ Fig. 2] ) are necessary to completely preserve the activity and regulation of this promoter (Fig. 2) . Expression from another truncated promoter region containing only 80 bp upstream of the azlB coding region (as in pBB532 [ Fig. 2] ) was significantly derepressed in minimal medium and slightly increased in nutrient broth medium (Fig. 2A) . In the ⌬azlB2 mutant, expression from this promoter was increased an additional 1.5-to 2.4-fold ( Fig. 2A) . This shows that major sites required for negative autoregulation of the azlB promoter are located upstream of the Ϫ80 position, with an additional site (or a partial site) downstream of this position (Fig. 2) . In accordance with this conclusion, when a truncated, derepressed azlB promoter governed expression of an azlBCЈ-lacZ fusion containing a full-length azlB gene (as in pBB536 [ Fig. 2A]) , it resulted in intermediate expression of this fusion ( Fig. 2A) . This is apparently due to the ability of overproduced AzlB to negatively regulate this truncated promoter, though with low efficiency. The apparent moderate overproduction of AzlB in such a strain had no other observable consequences.
The truncated, derepressed azlB promoter (as in pBB532 [ Fig. 2A] ) was still subject to growth phase-dependent regulation in both azlB ϩ and ⌬azlB2 cells (data not shown), consistent with these effects being independent of azlB negative autoregulation (Fig. 4) . Activity of this promoter did not reach the same level as with the full-length azlB-lacZ fusion even in the ⌬azlB2 mutant ( Fig. 2A) , indicating that some upstream sequences are important for maximal promoter efficiency. Thus, the deletion analysis localized the azlB promoter within 80 bp upstream of its coding region. This segment contains sequences with similarity to Ϫ10 and Ϫ35 regions of A -type promoters (Fig. 2B) . Other sequences important for negative autoregulation, growth rate-dependent regulation, and high promoter activity are localized within 135 bp upstream of the azlB coding region.
Organization of the azl operon. Downstream of azlB, we found two open reading frames, azlC and azlD, that might belong to an operon with azlB. A ⌬azlB2CD-lacZ transcriptional fusion, containing an in-frame deletion within the azlB sequence (as in pBB530 [ Fig. 2A] ) and integrated at the amyE locus, was regulated according to the same pattern as the full-length azlB-lacZ fusion ( Fig. 2A and data not shown) . A ⌬azlB3CD-lacZ fusion, with a more extensive deletion that removed the azlB promoter (as in pBB531 [ Fig. 2A]) , was not induced in the wild-type strain in nutrient broth medium and was not derepressed in the ⌬azlB2 mutant ( Fig. 2A and data  not shown) . Thus, the promoter located upstream of azlB determines the bulk of azlD, and presumably azlC, expression, i.e., these three genes form an operon. In addition, the operon apparently has at least one internal promoter, downstream from the HindIII 3 site, because ⌬azlB3CD-lacZ and azlЈCD-lacZ fusions that lack the azlB promoter (as in pBB531 and pBB528 [ Fig. 2A] ) have residual activities in both minimal and nutrient broth media. Activity of this promoter, in contrast to the activity of the azlB promoter, did not depend on the allelic state of the azlB gene ( Fig. 2A) and increased three-to fourfold in stationary phase in minimal medium (data not shown). azlB is the first example of a gene coding for an Lrp-like protein shown to be cotranscribed with other genes.
We also checked if the previously identified brnQ gene (5), located ϳ170 bp downstream from the azlD gene and transcribed in the same direction (Fig. 1) , could belong to the azl operon. A ⌬azlB2CD-brnQ-lacZ fusion (as in pBB533 [ Fig.  2A] ) was expressed at a much higher level in the ⌬azlB2 mutant than in a wild-type strain in both minimal and nutrient broth media (Fig. 2A). orf105 (5) , partially overlapping the 3Ј end of the brnQ gene (Fig. 1) , could also be part of the azl operon. A translational orf105-lacZ fusion (as in pBB535 [ Fig.  2A] ) was integrated at the azl-brnQ locus to reconstruct the intact chromosomal DNA context upstream of this fusion. This fusion was highly derepressed in the ⌬azlB2 mutant in minimal and nutrient broth media ( Fig. 2A) . Both ⌬azlB2CD-brnQlacZ and orf105-lacZ fusions were subject to growth phasedependent regulation (data not shown). These results indicate coregulation and, very likely, coexpression of the brnQ and orf105 genes with the azlBCD operon.
Preliminary Northern blot experiments with RNA isolated from cells grown in DS nutrient broth medium, using a DNA fragment corresponding to azlB and part of azlC as a probe, showed a transcript of approximately 3,500 nucleotides in B. subtilis BB34 (azlB101) (data not shown). This transcript has a length consistent with a polycistronic azlBCD-brnQ-orf105 mRNA. A potential strong rho-independent transcription terminator was identified previously, immediately downstream of orf105 (5) at positions 6678 to 6711 with respect to the present sequence. A slightly shorter transcript was detected with RNA from strain BB274 (⌬azlB2), presumably reflecting the 0.3-kb deletion within azlB (data not shown). We could not detect any transcript in the wild-type strain 1A1, which is in agreement with much lower expression of corresponding lacZ fusions (Fig. 4) . Assuming that azlBCD, brnQ, and orf105 constitute an operon, we renamed brnQ and orf105 the azlE and azlF genes.
Role of the azlCDE genes in 4-azaleucine resistance and expression of the azl operon. Among four available mutations in which the azlB gene was completely inactivated, the ⌬azlB::ble mutation was unusual because it conferred an intermediate level of 4-azaleucine resistance, compared to the azlB101, ⌬azlB1, and ⌬azlB2 mutations. This property of the ble insertion suggested that expression of distal genes of the azlBCDEF operon may be involved in resistance to 4-azaleucine. An apparent candidate for such a role is the azlE (brnQ) gene, whose product is very similar to several proteins involved in branched-chain amino acid transport (43) ( Table 2 ) and which could be responsible for 4-azaleucine transport. Nevertheless, inactivation of the azlE gene by plasmid integration (see Materials and Methods) neither affected growth of nor conferred 4-azaleucine resistance to an azlB ϩ strain and did not alter the resistance of the ⌬azlB2 mutant (data not shown), indicating that azlE (and, most probably, the downstream azlF gene) is not involved in resistance to 4-azaleucine.
Inactivation of the azlC and azlD genes or of the azlD gene alone (see Materials and Methods) did not confer resistance to 4-azaleucine on an azlB ϩ strain but abolished the resistance of the ⌬azlB2 mutant (data not shown). Since azlC and azlD are derepressed in the ⌬azlB2 mutant, it seems that overexpression of AzlD or both AzlC and AzlD causes 4-azaleucine resistance. Thus, the lower resistance of the ⌬azlB::ble mutant may be due to (i) a partial polar effect of the ble gene insert reducing expression of the azlCD genes from the derepressed azlB pro-moter, (ii) reduced expression of the derepressed azlB promoter due to convergent transcription from the ble promoter, or (iii) the presence of an unidentified promoter within the ble insert that allowed expression of the azlCD genes independently of the azlB promoter (probably at an intermediate level, compared to those of other azlB mutants).
In accordance with results presented above, a deletion extending from azlC to azlE (as in pBB598 and pBB599 [ Fig. 1]) did not cause resistance to 4-azaleucine in an azlB ϩ strain but abolished the resistance of the ⌬azlB2 mutant (data not shown). This deletion had no apparent effect on growth or expression of azlB-lacZ, azlЈCD-lacZ, or ⌬azlB2CDE-lacZ fusions (data not shown).
Dominance analysis of azlB alleles. As expected, the ⌬azlB2 and azlB101 mutations were recessive to a wild-type azlB allele integrated at the amyE locus (as in pBB526 [ Fig. 2A] ) with respect to azlB autoregulation and resistance to 4-azaleucine (data not shown).
Lack of a role of AzlB in glutamate synthase regulation. No effect of the ⌬azlB1 mutation on gltA-lacZ expression was observed. The mutation also did not affect expression of glnRlacZ or citB-lacZ fusions (data not shown).
Other genes in the azlB region. The open reading frame of 91 codons upstream of azlB is very similar to the Bacillus amyloliquefaciens barstar gene (Table 2) The largest open reading frame in the azlB region, located upstream of orf91, codes for a protein that is very similar to bacterial P-450 cytochromes (Table 2) . We called this gene cypA. No genes encoding putative electron carriers for P-450 cytochromes were found in the vicinity of cypA. Replacement of cypA with the ble gene did not affect growth in minimal or rich media.
No apparent growth defect was observed after disruption of Јorf182, which codes for a protein similar to several bacterial hydrolases (Table 2) .
DISCUSSION
Among the characterized members of the AsnC-Lrp family, only the Lrp protein of E. coli (and, presumably, nearly identical Lrp proteins of other enteric bacteria) is known to be involved in global regulation of cellular metabolism (9, 35) . Other proteins of this family seem to have more-specific regulatory functions, related to transport or utilization of amino The exact roles of the azlC and azlD genes in conferring resistance to 4-azaleucine remain mysterious. Induction of leucine biosynthesis enzymes could potentially explain this resistance, but no such induction was observed in an azlB mutant (46) . We hypothesize that AzlC and AzlD, when overexpressed, interfere with transport of 4-azaleucine and probably other branched-chain amino acids. Alternatively, these two proteins may be involved in pumping 4-azaleucine out of the cells. Hydropathy profiles of these proteins indicate that both are likely to be integral membrane proteins (Fig. 5) . Our results show that the target of their action is not the AzlE (BrnQ) product, though the facts that the three proteins are coexpressed and that proteins similar to AzlE are involved in branched-chain amino acid transport (25, 37, 43) suggest that AzlC or AzlD and AzlE may somehow interact functionally.
Other bacteria have multiple systems for branched-chain amino acid transport. Two such operons, livJ and livKHMGF of E. coli, are known to be regulated by the Lrp protein (22) . The product of another, as yet undiscovered branched-chain amino acid transport system in B. subtilis may be a target of overproduced AzlC and AzlD. If this were the case, azlE (brnQ) mutants that also overproduce AzlC and AzlD might be severely deficient in branched-chain amino acid transport. However, when liv::Tn917 or leuB::Tn917 mutations were introduced into a ⌬azlB2 azlE double mutant, a ⌬azlB2 ⌬azlCDE double mutant, or ⌬azlB2, azlE, and ⌬azlCDE single mutants, we did not observe any growth defect on minimal medium plates supplied with appropriate branched-chain amino acids (data not shown).
Two genes highly similar to azlC and azlD, orf244 and orf109 of Haemophilus influenzae (Table 2) , appear to be organized in an operon structure which includes a gene coding for a LysRtype transcription regulator as the promoter-proximal gene (19) . The putative product of E. coli orf245 (Table 2) is also similar to AzlC, albeit much less so. The product of the next downstream and overlapping E. coli gene, orf111, does not reveal any convincing sequence similarity to its B. subtilis and H. influenzae counterparts (Table 2) . Nevertheless, the three pairs of proteins show striking similarity in their hydropathy profiles (Fig. 5) , indicating that the products of these twocistron units might have similar functions.
Despite the proximity of their coding regions, expression of the azlC gene apparently is not coupled to translation of azlB inasmuch as two frameshift deletion mutations within the azlB gene, azlB101 and ⌬azlB1, that cause premature termination of azlB translation confer the same level of 4-azaleucine resistance (and, presumably, the same level of azlCD overexpression) as an in-frame deletion within azlB. It is not known if expression of the azlC and azlD genes is translationally coupled, though their coding regions overlap by 1 bp. In a more unusual fashion, the coding regions of the azlE and azlF genes overlap by 40 bp.
While this work was in progress, five additional B. subtilis gene products that belong to the AsnC-Lrp family of transcription regulators were identified. Some of them apparently form a separate group within this family, whereas others are close to archaeal members of the AsnC subfamily (Fig. 3) . Two of them, LrpA (YddO) and LrpB (YddP), may be involved in regulation of the glyA gene (11) ; the functions of the other proteins (YdaI, YugG, and YwrC) have not been described. It remains to be seen if any of these proteins is involved in glutamate synthase regulation in B. subtilis.
